[1]
Galazka, J.K. et al. 2023. Adiponectin as a novel predictive biomarker of multiple sclerosis course. Current Issues in Pharmacy and Medical Sciences. 36, 2 (Jun. 2023), 99–102. DOI:https://doi.org/10.2478/cipms-2023-0017.